Sirius Park Unveils Immunobiotech Postgrad Program in 2026
In 2026, the 'Sirius' science and technology park will unveil a new postgraduate program in immunobiotechnology. This comes as the second phase of operations begins mid-year, expanding its offerings and capabilities.
Currently, over 100 resident companies operate within 'Sirius'. The first phase of its laboratory complex, spanning 7,500 sq.m, was completed in September 2022. This phase alone can tackle tasks involving genetic technologies in pharmaceuticals, medicine, and agriculture.
The second phase, set to start mid-2026, will introduce a resource center for preclinical studies. It will also incorporate full-fledged industrial biotechnology, ecology, and medical chemistry. The laboratory complex is equipped with state-of-the-art technology, valued at 2.8 billion rubles. This expansion will complement the existing nine postgraduate programs, including the new immunobiotechnology course.
The opening of the second phase of the Sirius Laboratory Complex in 2026, as reported by journalist Elena Shmeleva, will significantly enhance the park's capabilities and educational offerings. This expansion is set to drive advancements in immunobiotechnology and related fields.
Read also:
- Mobility Sparks Unseen Organ: Surprisingly Active During Physical Activity
- Early Onset Puberty: Its Definition, Triggers, Risks, and Managing Strategies
- "Satanic Worship Owns the Spotlight in America: QAnon Spurring Modern Day Satanic Panic"
- Vaccine Deployment Amidst Adversity: HPV Inoculations Commence in Flood-Hit Regions Spite of Widespread Resistance from Society
